There are new rules governing commercial support of Continuing Medical Education (CME) programs which affect both CME providers and industry supporters, such as pharmaceutical, biotech and medical device companies. With Congress scrutinizing industry support of CME, the ACCME has issued new guidance, as well as a “Call for Comment” on the issue of industry funding. The new PhRMA Code (effective January 2009), along with independent state laws, has been adjusted to govern relationships between industry and physicians. Life sciences organizations, as well as CME providers, must keep abreast of these changes to maintain their accreditation status and ensure their internal policies are consistent with the latest laws and guidance.
This audio conference addresses how the new rules affect sponsors and providers and the best practices needed to comply.
The New Rules for CME Sponsors and Providers was presented by Maria D. Buckley, Nutter McClennen & Fish LLP and aired on 2009-01-08. For more details or to download this audio conference, please visit our site at www.fxconferences.com
